Cargando…

Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction

There is a paucity of data characterizing right ventricular performance in heart failure with preserved ejection fraction (HFpEF) using the gold standard of cardiovascular magnetic resonance imaging (CMR). We aimed to assess the proportion of right ventricular systolic dysfunction (RVD) in HFpEF and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanagala, Prathap, Arnold, Jayanth R., Singh, Anvesha, Khan, Jamal N., Gulsin, Gaurav S., Gupta, Pankaj, Squire, Iain B., Ng, Leong L., McCann, Gerry P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878207/
https://www.ncbi.nlm.nih.gov/pubmed/32737707
http://dx.doi.org/10.1007/s10554-020-01953-y
_version_ 1783650309437915136
author Kanagala, Prathap
Arnold, Jayanth R.
Singh, Anvesha
Khan, Jamal N.
Gulsin, Gaurav S.
Gupta, Pankaj
Squire, Iain B.
Ng, Leong L.
McCann, Gerry P.
author_facet Kanagala, Prathap
Arnold, Jayanth R.
Singh, Anvesha
Khan, Jamal N.
Gulsin, Gaurav S.
Gupta, Pankaj
Squire, Iain B.
Ng, Leong L.
McCann, Gerry P.
author_sort Kanagala, Prathap
collection PubMed
description There is a paucity of data characterizing right ventricular performance in heart failure with preserved ejection fraction (HFpEF) using the gold standard of cardiovascular magnetic resonance imaging (CMR). We aimed to assess the proportion of right ventricular systolic dysfunction (RVD) in HFpEF and the relation to clinical outcomes. As part of a single-centre, prospective, observational study, 183 subjects (135 HFpEF, and 48 age- and sex-matched controls) underwent extensive characterization with CMR. transthoracic echocardiography, blood sampling and six-minute walk testing. Patients were followed for the composite endpoint of death or HF hospitalization. RVD (defined as right ventricular ejection fraction < 47%) controls was present in 19% of HFpEF. Patients with RVD presented more frequently with lower systolic blood pressure, atrial fibrillation, radiographic evidence of pulmonary congestion and raised cardiothoracic ratio and larger right ventricular volumes. During median follow-up of 1429 days, 47% (n = 64) of HFpEF subjects experienced the composite endpoint of death (n = 22) or HF hospitalization (n = 42). RVD was associated with an increased risk of composite events (Log-Rank p = 0.001). In multivariable Cox regression analysis, RVD was an independent predictor of adverse outcomes (adjusted Hazard Ratio [HR] 3.946, 95% CI 1.878–8.290, p = 0.0001) along with indexed extracellular volume (HR 1.742, CI 1.176–2.579, p = 0.006) and E/E’ (HR 1.745, CI 1.230–2.477, p = 0.002). RVD as assessed by CMR is prevalent in nearly one-fifth of HFpEF patients and is independently associated with death and/or hospitalization with HF. The trial was registered retrospectively on ClinicalTrials.gov (Identifier: NCT03050593). The date of registration was February 06, 2017. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10554-020-01953-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7878207
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-78782072021-02-22 Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction Kanagala, Prathap Arnold, Jayanth R. Singh, Anvesha Khan, Jamal N. Gulsin, Gaurav S. Gupta, Pankaj Squire, Iain B. Ng, Leong L. McCann, Gerry P. Int J Cardiovasc Imaging Original Paper There is a paucity of data characterizing right ventricular performance in heart failure with preserved ejection fraction (HFpEF) using the gold standard of cardiovascular magnetic resonance imaging (CMR). We aimed to assess the proportion of right ventricular systolic dysfunction (RVD) in HFpEF and the relation to clinical outcomes. As part of a single-centre, prospective, observational study, 183 subjects (135 HFpEF, and 48 age- and sex-matched controls) underwent extensive characterization with CMR. transthoracic echocardiography, blood sampling and six-minute walk testing. Patients were followed for the composite endpoint of death or HF hospitalization. RVD (defined as right ventricular ejection fraction < 47%) controls was present in 19% of HFpEF. Patients with RVD presented more frequently with lower systolic blood pressure, atrial fibrillation, radiographic evidence of pulmonary congestion and raised cardiothoracic ratio and larger right ventricular volumes. During median follow-up of 1429 days, 47% (n = 64) of HFpEF subjects experienced the composite endpoint of death (n = 22) or HF hospitalization (n = 42). RVD was associated with an increased risk of composite events (Log-Rank p = 0.001). In multivariable Cox regression analysis, RVD was an independent predictor of adverse outcomes (adjusted Hazard Ratio [HR] 3.946, 95% CI 1.878–8.290, p = 0.0001) along with indexed extracellular volume (HR 1.742, CI 1.176–2.579, p = 0.006) and E/E’ (HR 1.745, CI 1.230–2.477, p = 0.002). RVD as assessed by CMR is prevalent in nearly one-fifth of HFpEF patients and is independently associated with death and/or hospitalization with HF. The trial was registered retrospectively on ClinicalTrials.gov (Identifier: NCT03050593). The date of registration was February 06, 2017. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10554-020-01953-y) contains supplementary material, which is available to authorized users. Springer Netherlands 2020-07-31 2021 /pmc/articles/PMC7878207/ /pubmed/32737707 http://dx.doi.org/10.1007/s10554-020-01953-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Paper
Kanagala, Prathap
Arnold, Jayanth R.
Singh, Anvesha
Khan, Jamal N.
Gulsin, Gaurav S.
Gupta, Pankaj
Squire, Iain B.
Ng, Leong L.
McCann, Gerry P.
Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction
title Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction
title_full Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction
title_fullStr Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction
title_full_unstemmed Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction
title_short Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction
title_sort prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878207/
https://www.ncbi.nlm.nih.gov/pubmed/32737707
http://dx.doi.org/10.1007/s10554-020-01953-y
work_keys_str_mv AT kanagalaprathap prevalenceofrightventriculardysfunctionandprognosticsignificanceinheartfailurewithpreservedejectionfraction
AT arnoldjayanthr prevalenceofrightventriculardysfunctionandprognosticsignificanceinheartfailurewithpreservedejectionfraction
AT singhanvesha prevalenceofrightventriculardysfunctionandprognosticsignificanceinheartfailurewithpreservedejectionfraction
AT khanjamaln prevalenceofrightventriculardysfunctionandprognosticsignificanceinheartfailurewithpreservedejectionfraction
AT gulsingauravs prevalenceofrightventriculardysfunctionandprognosticsignificanceinheartfailurewithpreservedejectionfraction
AT guptapankaj prevalenceofrightventriculardysfunctionandprognosticsignificanceinheartfailurewithpreservedejectionfraction
AT squireiainb prevalenceofrightventriculardysfunctionandprognosticsignificanceinheartfailurewithpreservedejectionfraction
AT ngleongl prevalenceofrightventriculardysfunctionandprognosticsignificanceinheartfailurewithpreservedejectionfraction
AT mccanngerryp prevalenceofrightventriculardysfunctionandprognosticsignificanceinheartfailurewithpreservedejectionfraction